syrup hybrid application [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2017-09-07 16:10 (2856 d 03:47 ago) – Posting: # 17792
Views: 6,086

Dear Aga,

❝ If we would go 10.3 - how we should prove equivalence with this tricky syrup? Bioequivalence - because the product is not pharmaceutically equivalent? or can we somehow prove pharmaceutical equivalence with double dose vs single dose? Is it possible?


I really meant what I said - this can be perceived completely heterogeneously between countries. You may get as many answers as there are agencies. Therefore, take scientific advices (pl.) and try to rely on that. They may need in vivo studies, or they may not. They may need ther. equivalence in stead of bioequivalence, or they may not. They may let you get away with some in vitro work, or they may not. They may accept a bunch of literature, or they may not. They may be totally paranoid and conservative because you are doing something related to children, or they may not.
Request scientific advice. Even if there is no budget and no time.:-)

Note also that BE does not have the same definition in EU and US.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,426 posts in 4,929 threads, 1,680 registered users;
23 visitors (0 registered, 23 guests [including 11 identified bots]).
Forum time: 19:57 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5